Latest news
Matsumoto Yushi-Seiyaku : Q1 FY2027 delivered robust revenue and profit growth, with upwardly revised full-year guidance - TradingViewTradingView · Mon, 10 Aug 2026 08:09:00 GMTEnergenesis Biomedical partners with Taiwan Tanabe Seiyaku to develop topical drug for diabetic foot ulcers - BioSpectrum AsiaBioSpectrum Asia · Fri, 07 Aug 2026 19:18:45 GMTEnergenesis Biomedical and Taiwan Tanabe Seiyaku Enter Joint Development Agreement for ENERGI-F703DFU - PR NewswirePR Newswire · Thu, 06 Aug 2026 23:00:00 GMTTABLE-Dai-ichi Kogyo Seiyaku Co Ltd -2026 6-month group forecast - TradingViewTradingView · Wed, 29 Jul 2026 07:00:26 GMT